Akero Therapeutics (AKRO) X Mentions Statistics 2025

22 65.6%

1W 83.3%

Est. daily mentions of Cashtag on X.

Similar companies

Company		X Mentions
	Amgen AMGN	29 34.1%
	Gilead Sciences GILD	38 50.6%
	Inovio Pharmaceuticals INO	8 38.5%
	Anavex Life Sciences AVXL	4 76.5%
	BridgeBio Pharma BBIO	7 16.7%

Analyzing X Mentions, how is Akero Therapeutics performing compared to its industry peers?

Akero Therapeutics underperforms its industry peers when it comes to X Mentions, ranking in the 2nd percentile.

Why should an investor track X mentions?

Investors should track mentions of Akero Therapeutics on X because sudden increases in activity often reflect shifts in retail interest, sentiment, or breaking news. These signals can precede sharp price movements, offering valuable context for timing trades or identifying emerging opportunities.

Sentiment on X

The sentiment score for Akero Therapeutics on X is 79 (out of 100). This is considered bullish. Sentiment today is up compared to the 30 moving average.

Top Mentions

Akero Therapeutics $AKRO is being bought by Novo $NVO It is up 16% today. Did someone know? Hard to...

Oct 9 - 10 retweets

6⃣0⃣🦈 Shark Dentist $DGNX $AKRO $NEOG $TMC $USAR $RACE $PLUG $AZZ Rebel's Edge 🏴‍☠️...

Oct 9 - 5 retweets

$AKRO drug came from $AMGN .. that didn’t want to get it back. AMGN struggling with obesity and no...

Oct 9 - 4 retweets

$AKRO Looks like Big Pharma is thirsty for acquisitions after the picture around tariffs and MFN is more...

Oct 9 - 3 retweets

$AKRO Akero Therapeutics has entered into a definitive agreement to be acquired by Novo Nordisk$NVO for...

Oct 9 - 2 retweets

About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

Top Stocks

Our Data

Datasets
Stock alerts
AI Stock Picks
AI Stock Picks - Results
House & Congress Trading
Earnings Calendar
Meme Stocks
Threads Users
Stock Predictor
Stock Picking Reviews
Stock Trading Signals
Index

AltIndex

News
Pricing
Sign up
Log in
API
Journalist Access
Data Disclaimer
Contact

Akero Therapeutics (AKRO) - X Mentions

Similar companies

Amgen

Gilead Sciences

Inovio Pharmaceuticals

Anavex Life Sciences

BridgeBio Pharma